doi: 10.1038/nm0814-796.
Letter campaign sought to pressure FDA action on stem cell clinics
- PMID: 25100513
- DOI: 10.1038/nm0814-796
Item in Clipboard
Letter campaign sought to pressure FDA action on stem cell clinics
Nat Med.
2014 Aug.
No abstract available
Similar articles
-
Stem cells. U.S. regulation of stem cells as medical products.Science. 2012 Dec 7;338(6112):1296-7. doi: 10.1126/science.1229918. Science. 2012. PMID: 23224541 No abstract available.
-
FDA should stand firm on stem-cell treatments.Nature. 2016 Jul 7;535(7610):7-8. doi: 10.1038/535007b. Nature. 2016. PMID: 27383946 No abstract available.
-
FDA challenges stem-cell clinic.Nature. 2010 Aug 19;466(7309):909. doi: 10.1038/466909a. Nature. 2010. PMID: 20725009 No abstract available.
-
The US Food and Drug Administration Modernization Act of 1997: impact on consumers.Clin Ther. 1998;20 Suppl C:C20-5. doi: 10.1016/s0149-2918(98)80004-0. Clin Ther. 1998. PMID: 9915086 Review.
-
Assessment of US pathway for approving medical devices for rare conditions.BMJ. 2014 Jan 17;348:g217. doi: 10.1136/bmj.g217. BMJ. 2014. PMID: 24443478 Review. No abstract available.
Cited by
-
Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study.Stem Cell Res Ther. 2021 Mar 18;12(1):189. doi: 10.1186/s13287-021-02254-4. Stem Cell Res Ther. 2021. PMID: 33736697 Free PMC article.
References
-
- Nature. 2014 Jun 19;510(7505):336-7 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
